News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Finance
PDL BioPharma, Inc. (PDLI) Announces $40 Million Financing Transaction With CareView Communications 6/30/2015
ViewRay Secures Up To $50M In Debt Financing From CRG 6/30/2015
Inari Medical Announces Closing Of $12.4 Million Venture Financing 6/30/2015
Guided Therapeutics Announces $4 Million Private Placement 6/30/2015
Cardax Pharmaceuticals Inc. Raises Additional $500,000 In Financing 6/30/2015
Inhibikase Therapeutics Awarded $1.54 Million To Advance Its Proprietary RAMP Chemistry Program To The Clinic 6/29/2015
Zosano Pharma, Inc. Announces $15 Million Debt Financing 6/29/2015
Sunshine Heart Exercises $2 Million Milestone Advance From Silicon Valley Bank 6/29/2015
Contract Research Organization WCCT Global Receives Large Investment From Asian Equity Firm 6/29/2015
The National Parkinson Foundation's Moving Day Fall 2014 Walks Fund Nearly $1 Million In Parkinson's Programs 6/29/2015
Sarepta (SRPT) Secures $40 Million In Debt Financing 6/29/2015
CAPNIA, Inc. Announces Commencement Of Series B Warrant Exchange Offer 6/26/2015
Sebacia Announces Series C Financing To Advance Innovative Dermatology Treatment For Acne 6/25/2015
Novasep Invests €10 Million To Reinforce Its Bioconjugation Services 6/25/2015
Portage Biotech Completes Non-Brokered Private Placement In Two Tranches For A Total Proceeds Of US$ 5,155,080 6/25/2015
Viratherapeutics Raises €3.6 Million In The First Closing Of A Series A Financing Round To Advance Its Novel Oncolytic Virus Platform 6/24/2015
Calcivis Raises £4.5m To Drive Development Of The Calcivis Caries Activity Imaging System Through To Commercialisation 6/24/2015
Aethlon Medical (AEMD) Announces $6 Million Equity Investment 6/24/2015
Bionic Vision Technologies Raising $10 Million for Further Bionic Eye Trial 6/24/2015
Highland Therapeutics Announces Closing Of US$50 Million Financing 6/24/2015
SwRI, UTSA Invest In Two New Joint Research Projects 6/24/2015
Clementia Rakes in $60M for Pipeline Development 6/23/2015
Ankasa Regenerative Therapeutics Nabs $8.5 Million in First Tranche of $17 Million Series A Financing 6/23/2015
Biodesix, Inc. Raises Another $11M 6/23/2015
Novoteris, LLC Announces $2.8 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. To Support Development Of Inhaled Nitric Oxide Antimicrobial Therapy 6/23/2015
ADMA Biologics, Inc. Secures Up To $21 Million Loan Commitment From Oxford Finance 6/22/2015
Philanthropists Unite To Accelerate Global Fight Against Tuberculosis With Combined $20 Million Gift To Broad Institute 6/22/2015
Western Oncolytics Closes $2.5 Million Series A To Advance Cancer Immunotherapy 6/22/2015
Bayer (BAY) To Infuse $4.54 Billion In R&D For 2015 6/19/2015
TapImmune Inc. (TPIV) Announces Immediate Infusion of $2.5 Million Dollars From Largest Institutional Investor 6/19/2015
PRANA Biotechnology (PRAN) Receives $6.8 Million R&D Tax Incentive Refund 6/19/2015
GlaxoSmithKline (GSK) Pours $95 Million into Cell Research Institute in Quest for New Drugs 6/18/2015
Parnell Pharmaceuticals Holdings Announces $11 Million Secured Term Loan Facility 6/18/2015
Johnson & Johnson (JNJ) Spinout PrEP Biopharm Raising $25 Million 6/18/2015
Florida Institute Funds Tampa-Based TransGenex Nanobiotech 6/18/2015
Cure Forward Receives $15 Million In Series A Financing 6/18/2015
Florida Institute Funds Tampa-based TransGenex Nanobiotech, Inc. 6/18/2015
Bay Area's CytomX Bags $70 Million; IPO on the Horizon? 6/17/2015
Avalon and GlaxoSmithKline (GSK) Bankroll Three More Biotech Startups 6/17/2015
Atopix Secures Funding To Broaden Development Of CRTH2 Antagonists For TH2-Mediated Disease 6/17/2015
Ontario Centres of Excellence Inc. Release: $1.5M To Accelerate Drug Discovery Within The Quebec-Ontario Life Sciences Corridor 6/17/2015
ARCA biopharma Announces Closing Of $37 Million Private Placement 6/17/2015
Zymergen Announces $44 Million In Financing From Data Collective, True Ventures, Draper Fisher Jurvetson, And Other Notable Investors 6/17/2015
BIO2015 EXCLUSIVE: DelMar Pharmaceuticals Files for $8M Fund Raise, BioSpace (DHX) Learns 6/17/2015
Bay Area's Zymergen Snags $44 Million 6/16/2015
Kezar Life Sciences Closes $23M Series A Financing 6/16/2015
Intellirod Spine Raises Capital And Obtains ISO Certification 6/16/2015
MaRS Innovation Release: Ontario Government Invests $1 Million In Toronto's Neuroscience Catalyst Consortium 6/16/2015
Vaccine Specialist AFFiRiS AG Successfully Completes Financing Round 6/16/2015
Tute Genomics Closes Additional Series A1 Funding With Strategic Investment From Intermountain Healthcare, Healthbox, And Tencent 6/16/2015
Milestone Pharmaceuticals Closes US$17 Million Series B Financing To Complete Phase 2 Clinical Studies For MSP-2017 6/15/2015
GrowBLOX Receives Funding To Complete Construction Of Nevada Cultivation Facility 6/15/2015
‘Call For Science’ To Find Cure For Alzheimer’s Disease: Health Connexions Launches A Ground-Breaking New $100 Million Program To Fund Alzheimer’s Solutions 6/12/2015
Unum Scores $65 Million 6/11/2015
MIT Phenom's Science Cranks Out Another Startup XTuit Pharma 6/11/2015
BioAtla Receives $30 Million Equity Investment From China-based Investor Group 6/11/2015
ARCA biopharma Reels In $37 Million 6/11/2015
BioAdvance Portfolio Companies Attract $85 Million Of Capital In 12 Months 6/11/2015
EpiVax, Inc. Reports $5.2 Million For New Q Fever Vaccine Means There Is Hope For Vaccines On Demand 6/11/2015
Melinta Banks $67 Million for Skin Infection Antibiotic 6/10/2015
CTI BioPharma Amends Loan Agreement 6/10/2015
Life Science Firms Froth as VC Firm Clarus Ventures Nabs Another $500 Million 6/10/2015
Merck & Co. (MRK), New England Patriots Owner Wager $30 Million on Cambridge Startup, Spero 6/9/2015
Phagelux Announces $10 Million Financing 6/9/2015
Twist Bioscience Raises $37 Million In Oversubscribed Series C Financing 6/9/2015
Luqa Pharmaceuticals Completes US$15M Series A Financing 6/9/2015
Biovica Receives €682,000 In EU Funding 6/9/2015
Celtaxsys, Inc. Secures $45M In Capital To Fund Novel Anti-Inflammatory Phase 2 Programs In Cystic Fibrosis And Acne 6/8/2015
Avilex Pharma Receives Wellcome Trust Translation Award To Advance Their Ischemic Stroke Program And Raises In Total 28 MIO DKK (3.75 MIO EUR) 6/8/2015
Cerebain Biotech Receives Financial Commitment Of Two Million Dollars 6/8/2015
Soon-Shiong Nails $75 Million for Another Startup 6/5/2015
Teva (TEVA) Quietly Dumps Millions in Telemedicine Startup American Well 6/4/2015
Bay Area's Ardelyx (ARDX) Will Go It Alone on GI Drug As it Splits With AstraZeneca PLC (AZN) 6/4/2015
University of Southern California Receives $25 Million Gift To Name USC Tina And Rick Caruso Department Of Otolaryngology - Head And Neck Surgery And USC Caruso Family Center For Childhood Communication 6/4/2015
MyoPowers Raises € 4.5 Million From Truffle Capital, Novartis Venture Fund And Gran Plasa 6/3/2015
FL-Based Biotech, AmnioLife Closes $833K In Series A 6/3/2015
Auspherix Raises £6 Million To Progress Its Novel Antibiotics And Establishes UK Operations 6/3/2015
22nd Century Group, Inc. Announces Closing Of $6 Million Registered Direct Offering 6/3/2015
WuXi AppTec, Inc. Expands Investment In Instem Software Solutions 6/3/2015
Global Kinetics Corporation Closes $14.8 million Capital Raising 6/2/2015
BioRestorative Announces Conversion Of $5.15 Million Of Debt To Equity 6/2/2015
Celtaxsys, Inc. Receives $5M Research Award To Advance Once Daily, Oral Anti-Inflammatory Medicine Into Phase 2 CF Patient Lung Function Preservation Trial 6/2/2015
Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 6/2/2015
Rumor Has It: San Francisco's Foresite Capital Closing Out $450 Million Life Science Fund 6/1/2015
BioDelivery Sciences International (BDSI) Adds $20 Million In Debt Financing From MidCap Financial 6/1/2015
The Ontario Institute for Cancer Research Invests $4.6 Million To Support Pancreatic Cancer Research 6/1/2015
Eli Lilly (LLY) Announces The Pricing Terms Of Its Cash Tender Offer For Up To $1.6 Billion Aggregate Principal Amount Of Its Outstanding Debt Securities 5/29/2015
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $16 Million 5/29/2015
SCRA Technology Ventures Announces Approval 5/29/2015
Pronutria Bags $39M for Research, Possible Staff Expansion and Recruits Two Ex-Vertex (VRTX) Execs 5/28/2015
Bayer (BAY) Announces Four Strategic Priorities, Restructuring and No Job Cuts 5/28/2015
Rani Therapeutics Secures Series C Funding 5/27/2015
Mapi Pharma Closes $10 Million Investment Led By Shavit Capital 5/27/2015
Ontario Brain Institute Release: Focus On Brain: $10M For Breakthrough Technologies To Address Unmet Needs In Neurosciences 5/27/2015
Calimmune Completes $15 Million Series B Financing 5/27/2015
Asterias Biotherapeutics Receives $11.7 Million In Proceeds From Exercise Of Warrants 5/26/2015
QR Pharma Issues $5.7 Million Of Series A Preferred Stock 5/26/2015
Baycrest Health Sciences Release: Ontario, Canada To Invest $23.5 Million In New Brain Research Centre 5/26/2015
Ontario Bioscience Innovation Organization CAAP Program Receives FedDev Ontario Funding 5/22/2015
REGENXBIO Banks $70.5 Million As Gene Therapy Enjoys Revival 5/21/2015
Osage University Partners Closes Oversubscribed $215 Million Venture Capital Fund, Partners With Leading Universities 5/21/2015
New York's Kinex Expected to Hire 80 to 240 Immediately, 800 Over Next Two Years 5/20/2015
Billionaire Doubles Down On Valeant (VRX) 5/19/2015
PsiOxus Scores $38.5 Million Series C 5/19/2015
Three Former Genentech (RHHBY) Researchers Launch Neuroscience Company Denali Therapeutics With $217 Million 5/18/2015
HedgePath Pharmaceuticals To Receive $2.5 Million in Funding From Mayne Pharma 5/18/2015
OccuRx Launched With Up To AU$6.5 Million In Funding 5/18/2015
Amarillo Biosciences (AMAR) Summarizes New Plan After Filing For Banruptcy In January 5/18/2015
World's Richest Doctor Banks Another $100 Million for Cancer-Focused Startup NantBioscience 5/15/2015
Puma Biotech (PBYI) Founder Loses $250 Million on Disappointing Breast Cancer Drug Data 5/15/2015
Dyadic International, Inc. Receives Funding For New Advanced Biofuels Program 5/14/2015
Prima Biomed (PRR.AX): $15 Million Funding From U.S. Healthcare Fund Ridgeback 5/14/2015
OncoCyte Corporation Completes Equity Financing Round 5/14/2015
Life Science Startups Froth as VC Firm MPM Capital Closes $400 Million Funding Round 5/14/2015
BeiGene Co.,Ltd Nabs $97 Million 5/13/2015
Fueling The Biotech Revolution: Indie Bio Raises Funding For Biotech Startups To 250k Per Company 5/13/2015
Growblox Announces Commercialization Initiative And Financing 5/13/2015
NuSirt Biopharma Raises $6 Million In Series C Funding 5/13/2015
Inoviem Scientific Receives €545,000 ($611,000) From French Public Investment Bank Bpifrance 5/13/2015
China's Hutchison Medipharma Receives $18 Million In Payments From Eli Lilly (LLY) 5/13/2015
Quintiles (Q) Announces Completion Of Refinancing 5/13/2015
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS 5/12/2015
Navidea (NAVB) Secures $60 Million Loan 5/12/2015
JHL Biotech Successfully Raises US$45.6 Million Series C Financing 5/12/2015
Juventas Therapeutics, Inc. Adds $13.5 Million In New Financing And Expands Board Of Directors 5/12/2015
Sangui BioTech International Inc. (SGBI) Secures Financial Framework Of $5 Million Over Three Years 5/12/2015
Eli Lilly (LLY) Announces Cash Tender Offer For Up To $1.6 Billion Aggregate Principal Amount Of Its Outstanding Debt Securities And The Redemption Of Its 6.57% Notes Due 2016 5/12/2015
Bristol-Myers Squibb (BMY) Announces The Early Results Of Its Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities; Increases The Maximum Amount Of The Tender Offer 5/12/2015
Imprimis Pharmaceuticals (immy) Announces $15 Million Term Loan Agreement With Life Sciences Alternative Funding LLC 5/12/2015
Precision BioSciences Bags $25.6 Million Series A 5/11/2015
Prometheus Research Announces $1M In Expanded Funding From Public And Private Sectors, Sees Broader Applications For Their Integrated Registry Platform 5/11/2015
H&P Labs Announces Contribution From NRC-IRAP For New Antiviral Program 5/11/2015
H&P Labs Receives Financial Contribution From The Government Of Canada For New Antiviral Program 5/11/2015
Spyryx Biosciences Secures $18 Million In Series A Financing 5/7/2015
Bone Biologics Completes Financing With Hankey Capital, LLC 5/7/2015
NeuroVive Announces The Intention To Raise Additional Capital Through A Private Placement 5/7/2015
Cultivation Capital, Arch Angels And BioGenerator Announce Investment In Arvegenix 5/7/2015
Startup Symbiomix Grabs $41 Million to Fund Trial for a Newish Old Antibiotic 5/7/2015
Kymab Pulls In $90 Million to Speed Up Antibody Pipeline 5/7/2015
Adaptive Biotech Bags $195 Million In Largest Washington Fundraise This Year 5/7/2015
Oxford Finance And Silicon Valley Bank Close $17 Million Debt Facility With Labcyte Inc. 5/6/2015
Oxford Finance Provides $5 Million Term Loan Expansion To Edgemont Pharmaceuticals, LLC. 5/6/2015
Oxford Finance Provides $10 Million Debt Financing To Celula, Inc. 5/6/2015
Cytori Therapeutics, Inc. (CYTX) Prices Registered Direct Offering Providing For Up To $25 Million In Equity Financing 5/5/2015
Inovio Pharmaceuticals (INO) Closes $87.4 Million Underwritten Financing 5/5/2015
Themis’s Raises Up To EUR 10 Million In Series B 5/5/2015
Novo Nordisk A/S (NVO)'s $225 Million Hemophilia Facility Will Create 100 New Jobs 5/5/2015
Stressed GlaxoSmithKline (GSK) May Put $6.1 Billion Payout on Hold As New Chairman Arrives 5/4/2015
Tobira Therapeutics Inc. Completes Financing And Merger With Regado Biosciences, Inc. (RGDO) 5/4/2015
NeuroVigil Inc. Closes Second Financing Round 5/4/2015
SolaranRx Marks Melanoma Monday With A $100,000 Investment From STC.UNM 5/4/2015
Week In Review: WuXi PharmaTech Co., Ltd. Announces $3.3 Billion Go-Private Offer 5/4/2015
Mirna Therapeutics Rakes in $41.8 Million in Series D As Lonestar Bio Booms 5/1/2015
Oxford BioMedica PLC (OXB.L) Secures $50 Million 5/1/2015
Northwest Biotherapeutics (NWBO) Rakes In $28.5 Million 5/1/2015
Bay Area MyoKardia Snags $46 Million in Series B Financing Amid Rumors of Future IPO 5/1/2015
Despite Patent Battle Worth Billions, CRISPR Raises $64 Million in Series A & B Rounds 4/30/2015
Newron Pharmaceuticals (NWRN) Completes CHF24.3M/US$25.5 Million In Private Placement From Leading EU And US Investors 4/30/2015
The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 4/30/2015
Merus Labs International Inc. Announces Closing Of C$60.0 Million Bought Deal Financing 4/30/2015
Boston Startup Intarcia Nabs $225 Million in New Financing, Looks to Double Employment 4/29/2015
Pamlico BioPharma Announces Financing Led By Accele Venture Partners 4/29/2015
GW Pharma (GWPH) Raises $179.2 Million NASDAQ Cash 4/29/2015
cytena, A University of Freiburg Spin-Off, Received EUR 1.1 Million Of Seed Capital From HTGF And A Private Investor 4/29/2015
Protea Biosciences, Inc. Announces Completion Of Private Placement 4/28/2015
InCarda Therapeutics Completes Over $5 Million Private Financing 4/28/2015
PEP-Therapy Raises €1.3 Million In Seed Capital 4/28/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/27/2015
Amarantus BioSciences, Inc. Closes $5 Million Preferred Stock Financing 4/27/2015
South San Francisco's Veracyte, Inc. (VCYT) Brings In $40 Million 4/23/2015
Jounce Infused With $56 Million to Develop Cancer Immunotherapy Programs 4/23/2015
Stealth SoCal Startup Metacrine Eyes $33 Million and Talent-Cash From Seragon Alums? 4/22/2015
New York VC Firm Oberland Capital Secures $425 Million for Life Sciences, Medtech 4/22/2015
SciFluor Life Sciences, LLC Locks In $30 Million and Taps Ex-Neurogen Corporation (NRGN) CEO as Chairman 4/22/2015
Cambridge's Dimension Therapeutics Nabs $65 Million 4/21/2015
Brandon Capital Partners Dedicates $200 Million to Seeking the Next Big Thing 4/20/2015
Medican Enterprises Extends Closing On Two Phoenix Area Properties 4/17/2015
Boston VC Firm Atlas Venture Set Sights on Biotech Startups With $280 Million Fund and New Home 4/17/2015
Life Science Start-Ups Salivate, As NEA Announces Record-Setting $3.1B Funds 4/16/2015
This San Francisco Startup Wants to be the Salesforce of Biotech 4/16/2015
Biologics, Inc. (NC) Secures Over $29 Million In Copay Assistance For Cancer Patients In 2014 4/15/2015
Ascenion GmbH's Portfolio Company OMEICOS Therapeutics Raises EUR 6.2 Million In Series A To Advance Lead Candidate In Atrial Fibrillation 4/15/2015
StemBioSys Closes $8 Million Series A Financing 4/14/2015
Castle Biosciences Secures $6 Million Credit Facility From Silicon Valley Bank 4/14/2015
Clyde Biosciences, A Leading Drug Toxicity Testing Company, Closes Series A Investment 4/14/2015
Innocrin Raises $28 Million in Series D Financing 4/14/2015
Voyager Therapeutics Snags $60 Million With "Crossover" Investors as Analysts Predict an IPO 4/13/2015
Fidelity CEO Uses Personal Fortune to Bet on Cancer Related IPOs Like Coherus, Adaptimmune and Blueprint Medicines 4/13/2015
Angionetics Initial Equity Funding To Advance As Independent Company To Develop And Commercialize Phase 3 Generx Gene Therapy Product Candidate 4/13/2015
Oxford Finance Closes $20 Million Debt Facility With Inhibrx 4/10/2015
Belgian Start-Up UgenTec Receives Funding From European Investors 4/10/2015
Matinas BioPharma Completes Private Placement Of $10 Million 4/10/2015
Embera NeuroTherapeutics, Inc. Secures A-2 Financing To Advance EMB-001 For Addictions Through Phase 1 Clinical Trial 4/10/2015
Silence Therapeutics Scrounges Up $58 Million to Expand RNA Research 4/9/2015
Edge Therapeutics Banks $72.5 Million for Phase III Brain Hemorrhage Study 4/9/2015
Ark Biosciences Of Shanghai Completes Series A Funding 4/8/2015
Raising $10M in Series A, Alzheon CEO Bets He Can Beat Biogen (BIIB) With World's First Alzheimer's Drug 4/8/2015
Quebec Breast Cancer Foundation Release: Breast Cancer: $4.5 Million For Nine Homegrown Researchers 4/7/2015
Nabriva Raises $120 Million, Headed to Phase III for New Antibiotic 4/7/2015
True North Therapeutics CEO Delivers With $35 Million to Take Lead Candidate Into Clinical Trial 4/7/2015



//-->